Association between low-density lipoprotein cholesterol-lowering genetic variants and risk of type 2 diabetes: a meta-analysis
<strong>Importance:</strong> Low-density lipoprotein cholesterol (LDL-C)–lowering alleles in or near NPC1L1 or HMGCR, encoding the respective molecular targets of ezetimibe and statins, have previously been used as proxies to study the efficacy of these lipid-lowering drugs. Alleles nea...
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
American Medical Association
2016
|